Rnai inhibition of serum amyloid a for treatment of glaucoma

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 31/7088 (2006.01) A61K 31/713 (2006.01) A61P 27/06 (2006.01) C07K 14/775 (2006.01) C07H 21/02 (2006.01) C12N 15/12 (2006.01)

Patent

CA 2591403

RNA interference is provided for inhibition of serum amyloid A mRNA expression in glaucomas involving SAA expression.

L'invention concerne une interférence d'ARN destinée à inhiber l'expression d'ARNm d'amyloïde sérique A dans des glaucomes impliquant l'expression de SAA.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Rnai inhibition of serum amyloid a for treatment of glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rnai inhibition of serum amyloid a for treatment of glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rnai inhibition of serum amyloid a for treatment of glaucoma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1383467

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.